This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Washington. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Gabriel Jacob Rocklin: Innovator in Influenza Treatment
Introduction
Gabriel Jacob Rocklin is a notable inventor based in Seattle, Washington. He has made significant contributions to the field of virology, particularly in the development of treatments for influenza. His innovative work has the potential to impact public health positively.
Latest Patents
Rocklin holds a patent for "De novo designed hemagglutinin binding proteins." This patent discloses polypeptides that bind to viral hemagglutinin, along with methods for their use in treating or limiting influenza infection and diagnosing influenza infection. This invention represents a significant advancement in the fight against influenza.
Career Highlights
Rocklin is affiliated with the University of Washington, where he conducts research and develops his innovative ideas. His work is characterized by a strong focus on practical applications that can lead to improved health outcomes.
Collaborations
He has collaborated with notable colleagues, including David Baker and Aaron Arthur Chevalier. These partnerships enhance the research environment and foster innovation in their respective fields.
Conclusion
Gabriel Jacob Rocklin is a prominent figure in the realm of influenza research and treatment. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile